Thyss A - Search Results

1

[Cardiotoxicity of 5-fluorouracil. Spasm or direct myocardial toxicity?].

Thyss A, Falewee MN, Leborgne L, Viens P, Schneider M, Demard F. Thyss A, et al. Bull Cancer. 1987;74(4):381-5. Bull Cancer. 1987. PMID: 3663962 French.

2

[Dihydropyrimidine dehydrogenase activity in lymphocytes: predictive factor for 5-fluorouracil clearance].

Etienne MC, Milano G, Fleming RA, Thyss A, Renée N, Schneider M, Demard F. Etienne MC, et al. Among authors: thyss a. Bull Cancer. 1992;79(12):1159-63. Bull Cancer. 1992. PMID: 1304835 French.

3

[Optimization using the pharmacokinetics of the therapeutic index of CDDP-5 FU treatment over 5 continuous days].

Milano G, Santini J, Thyss A, Reneè N, Veins P, Chauvel P, Schneider M, Demard F. Milano G, et al. Among authors: thyss a. Bull Cancer. 1989;76(8):905-8. Bull Cancer. 1989. PMID: 2620123 French. No abstract available.

4

5-FU therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancer.

Santini J, Milano G, Thyss A, Renee N, Viens P, Ayela P, Schneider M, Demard F. Santini J, et al. Among authors: thyss a. Br J Cancer. 1989 Feb;59(2):287-90. doi: 10.1038/bjc.1989.59. Br J Cancer. 1989. PMID: 2930694 Free PMC article.

5

[Population study of dihydropyrimidine dehydrogenase in cancer patients].

Etienne MC, Milano G, Renée N, Lagrange JL, Dassonville O, Thyss A, Schneider M, François E, Fleming R, Demard F. Etienne MC, et al. Among authors: thyss a. Bull Cancer. 1995 Sep;82(9):705-10. Bull Cancer. 1995. PMID: 8535028 French.

6

No effect of dose, hepatic function, or nutritional status on 5-FU clearance following continuous (5-day), 5-FU infusion.

Fleming RA, Milano GA, Etienne MC, Renée N, Thyss A, Schneider M, Demard F. Fleming RA, et al. Among authors: thyss a. Br J Cancer. 1992 Oct;66(4):668-72. doi: 10.1038/bjc.1992.335. Br J Cancer. 1992. PMID: 1419604 Free PMC article.

7

Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patients.

Fleming RA, Milano G, Thyss A, Etienne MC, Renée N, Schneider M, Demard F. Fleming RA, et al. Among authors: thyss a. Cancer Res. 1992 May 15;52(10):2899-902. Cancer Res. 1992. PMID: 1581906

8

Influence of sex and age on fluorouracil clearance.

Milano G, Etienne MC, Cassuto-Viguier E, Thyss A, Santini J, Frenay M, Renee N, Schneider M, Demard F. Milano G, et al. Among authors: thyss a. J Clin Oncol. 1992 Jul;10(7):1171-5. doi: 10.1200/JCO.1992.10.7.1171. J Clin Oncol. 1992. PMID: 1607921

9

Response to chemotherapy as justification for modification of the therapeutic strategy for pharyngolaryngeal carcinomas.

Demard F, Chauvel P, Santini J, Vallicioni J, Thyss A, Schneider M. Demard F, et al. Among authors: thyss a. Head Neck. 1990 May-Jun;12(3):225-31. doi: 10.1002/hed.2880120306. Head Neck. 1990. PMID: 2358333

10

Toxicity of a combination of ABVD chemotherapy and mediastinal irradiation for Hodgkin's disease patients with massive initial mediastinal involvement.

Lagrange JL, Thyss A, Caldani C, Héry M, Schneider M, Bensadoun JR. Lagrange JL, et al. Among authors: thyss a. Bull Cancer. 1988;75(8):801-6. Bull Cancer. 1988. PMID: 2460169

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

285 results

Search Page

Filters